Roche, Ionis RNA drug scores in kidney disease study

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 23 Sept, 16:21 UTC

The results position Roche to bring a new kind of medicine to market for IgA nephropathy, a disease that’s drawn considerable attention of late from drugmakers.

science

Sources

• T2Roche, Ionis RNA drug scores in kidney disease studyBioPharma Dive / Healthcare Dive / MedTech Dive23 Sept, 16:21